CASK and prostate carcinoma: The lncRNA AATBC binds miR‐1245b‐5p as an oncogene and promotes malignant progression of prostate cancer through the miR‐1245b‐5p/LIN2 axis, and the downstream molecule LIN2 plays a pro‐oncogenic role in prostate cancer progression [95].